Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

That brings up an important point (re: the parti

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155385
(Total Views: 576)
Posted On: 05/19/2021 10:22:13 PM
Posted By: CGC
Re: Goosebumps #91016

That brings up an important point (re: the particular FDA branch) that Dr J mentioned. He seems a person that looks for solutions and innovative angles.

However, I didn't hear it as Dr J as saying anything about (or attacking) the relationship between the FDA and Dr NP. Instead I heard it as a broader reference to the relationship between FDA and CytoDyn- which could indicate blocks with the process, him (love Dr J's fire, precision and passion and maybe they were whiny babies about that), the end points, miscommunication, the paperwork, investor voices, the RO history, seeing dosage differently, etc. I will go back and listen again if I have time. Agree, we don't really know but I missed any sort of attack.

________________

Posted On: 05/19/2021 7:57:53 PM
Posted By: Goosebumps
Re: melsdollars #90936
Instead of attacking the relationship between the FDA and Nader as Dr J has done. I don’t know who really knows what is going on for sure. The timeline of Dr J as a science officer was short and he probably attend few meetings and to know the complete relationship would take much more evaluation I would think. We see that Nader bows to the power that is the FDA and only seeks to respect the process.

Dr. J said something interesting as a possible solution to a possible compromised relationship. Leronlimab has been classed as a viral inhibitor and that is the branch of the FDA that is reviewing Leronlimab. His suggestion is to have Leronlimab reviewed and guided by the pulmonary branch of review and receive a fresh start and his reasoning was that leronlimab in Covid is primarily a lung inflammation reducer and blocker of cells with inflammation.

Will this solve a possible problem with relationships? Who knows but it could be a fresh start and worth a suggestion. I am not convinced a short view of Dr. J is as reliable as we would hope. I think the world of him but opinions are opinions and we rationalize our relationships in different ways.


Read More: https://investorshangout.com/post/newpost/605...z6vMpBEpJY


(3)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us